PMED Paradigm Medical Industries Granted CE Mark for Next Generation UBM Device

Joined Today: 0

Message #2
From: Stock News Bot
Date: March 2, 2005 09:27:53 AM

PMED Paradigm Medical Industries Granted CE Mark for Next Generation UBM Device

Paradigm Medical Industries Granted CE Mark for Next Generation UBM Device SALT LAKE CITY Paradigm Medical Industries, Inc. Aziz A. Mohabbat, 801-977-8970 Paradigm Medical Industries, Inc. today announced it has been awarded the CE Mark for a new generation ultrasound biomicroscope (UBM). The CE Mark will enable the Company to market the device in 19 Western European countries and some parts of the Pacific Rim. "The P60 UBM, which received clearance from RWTUV Systems GmbH, is a fourth generation device that is a very sophisticated microprocessor-based, multi-frequency ultrasound biomicroscope that allows users to acquire and view high-resolution images of the anterior segment of the eye," said Paradigm Medical's Chief Operating Officer, Aziz A. Mohabbat. "We expect to begin product sales in Europe immediately." Paradigm Medical was granted the CE Mark for its latest version of UBM, the P45, in 2001, and has generated sales overseas since. The P45--and earlier versions--also has U. S. Food and Drug Administration (FDA) approval for use in the United States. The P60 represents the latest generation of UBM devices, and is believed to have better visual clarity and image flexibility than earlier versions. "The P60 can provide full sulcus-to-sulcus images of the eye in a single pass," Mr. Mohabbat added. "Using a precision linear tracking scan head, as well as a B-Scan that produces two-dimensional plane views of the eye for diagnostic evaluation, the P60 represents the state of the art for high-resolution imaging of the eye. Images may be edited and enhanced, printed and saved to mass storage for improved patient diagnosis and record keeping." The UBM is used for viewing structures in the front half of the eye involved with glaucoma pathologies and related surgical filtering procedures. Glaucoma is the leading cause of blindness, affects one out of every five people over age 50. Some 75% of glaucoma goes undiagnosed because of the lack of sophisticated instrumentation. Lower frequency application provides a view of the retinal area of the eye and is used for diagnosis of trauma to the vitreous body. "The rapid acceptance of the P60 illustrates Paradigm Medical's commitment to improving on-time delivery and quality assurance for high-technology devices for the eye-care industry," Mr. Mohabbat noted. "The UBM is the Company's largest generator of revenues and has high gross profit margins. Expanding our marketing base for the UBM has been one of management's key strategies." Paradigm Medical Industries, Inc., currently develops, manufactures and markets surgical and diagnostic high-tech, proprietary equipment and consumable products for the medical industry. The Company's corporate headquarters are located at 2355 South 1070 West, Salt Lake City, Utah 84119. Call (801) 977-8970 or visit us at www.paradigm-medical.com. This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statement that could predict future events or outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements. Copyright © 2005 Business Wire. All reproduction, other than for an individual user`s reference, is prohibited without prior written permission. News Copyright © 2005 Interest!ALERT All rights reserved.

« Previous | Next » | All Messages | PMED Message Board Home | Ignore Poster